Libya vs Uruguay: Cause of death, by non-communicable diseases, ages 0-4, female
Libya
41.6%
in 2021
Uruguay
42.5%
in 2021
Libya rank
37th
Uruguay rank
34th
Cause of death, by non-communicable diseases, ages 0-4, female over time
- Libya
- Uruguay
How they compare
Uruguay currently reports 42.5% against 41.6% in Libya, a difference of 0.9%.
Across all 6 years both countries report, Uruguay has been ahead every year.
Libya ranks 37th and Uruguay ranks 34th of 185 countries.
Uruguay has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Libya | Uruguay | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 28.8% | 37.4% | 8.6% | Uruguay |
| 2010s | 39.3% | 44.2% | 4.9% | Uruguay |
| 2020s | 41.5% | 43.2% | 1.7% | Uruguay |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, female, Libya or Uruguay?
- Uruguay, at 42.5% against 41.6% in Libya as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4, female between Libya and Uruguay?
- 0.9%, with Uruguay ahead.
- How many years of comparable data are there for Libya and Uruguay?
- 6 years are reported by both, from 2000 to 2021.
- How do Libya and Uruguay rank globally for cause of death, by non-communicable diseases, ages 0-4, female?
- Libya ranks 37th and Uruguay ranks 34th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4, female (% of total female deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 0-4 due to non-communicable diseases divided by number of all female deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.